310 related articles for article (PubMed ID: 33764550)
1. Liver stiffness by magnetic resonance elastography is associated with increased risk of cardiovascular disease in patients with non-alcoholic fatty liver disease.
Park JG; Jung J; Verma KK; Kang MK; Madamba E; Lopez S; Qas Yonan A; Liu A; Bettencourt R; Sirlin C; Loomba R
Aliment Pharmacol Ther; 2021 May; 53(9):1030-1037. PubMed ID: 33764550
[TBL] [Abstract][Full Text] [Related]
2. Clinical Utility of an Increase in Magnetic Resonance Elastography in Predicting Fibrosis Progression in Nonalcoholic Fatty Liver Disease.
Ajmera VH; Liu A; Singh S; Yachoa G; Ramey M; Bhargava M; Zamani A; Lopez S; Mangla N; Bettencourt R; Rizo E; Valasek M; Behling C; Richards L; Sirlin C; Loomba R
Hepatology; 2020 Mar; 71(3):849-860. PubMed ID: 31556124
[TBL] [Abstract][Full Text] [Related]
3. Liver Stiffness Severity is Associated With Increased Cardiovascular Risk in Patients With Type 2 Diabetes.
Mangla N; Ajmera VH; Caussy C; Sirlin C; Brouha S; Bajwa-Dulai S; Madamba E; Bettencourt R; Richards L; Loomba R
Clin Gastroenterol Hepatol; 2020 Mar; 18(3):744-746.e1. PubMed ID: 31100460
[TBL] [Abstract][Full Text] [Related]
4. The impact of genetic risk on liver fibrosis in non-alcoholic fatty liver disease as assessed by magnetic resonance elastography.
Ajmera V; Liu A; Bettencourt R; Dhar D; Richards L; Loomba R
Aliment Pharmacol Ther; 2021 Jul; 54(1):68-77. PubMed ID: 33975381
[TBL] [Abstract][Full Text] [Related]
5. MR elastography-based liver fibrosis correlates with liver events in nonalcoholic fatty liver patients: A multicenter study.
Han MAT; Vipani A; Noureddin N; Ramirez K; Gornbein J; Saouaf R; Baniesh N; Cummings-John O; Okubote T; Setiawan VW; Rotman Y; Loomba R; Alkhouri N; Noureddin M
Liver Int; 2020 Sep; 40(9):2242-2251. PubMed ID: 32652744
[TBL] [Abstract][Full Text] [Related]
6. An individual patient data meta-analysis to determine cut-offs for and confounders of NAFLD-fibrosis staging with magnetic resonance elastography.
Liang JX; Ampuero J; Niu H; Imajo K; Noureddin M; Behari J; Lee DH; Ehman RL; Rorsman F; Vessby J; Lacalle JR; Mózes FE; Pavlides M; Anstee QM; Harrison SA; Castell J; Loomba R; Romero-Gómez M;
J Hepatol; 2023 Sep; 79(3):592-604. PubMed ID: 37121437
[TBL] [Abstract][Full Text] [Related]
7. Magnetic resonance elastography biomarkers for detection of histologic alterations in nonalcoholic fatty liver disease in the absence of fibrosis.
Qu Y; Middleton MS; Loomba R; Glaser KJ; Chen J; Hooker JC; Wolfson T; Covarrubias Y; Valasek MA; Fowler KJ; Zhang YN; Sy E; Gamst AC; Wang K; Mamidipalli A; Schwimmer JB; Song B; Reeder SB; Yin M; Ehman RL; Sirlin CB
Eur Radiol; 2021 Nov; 31(11):8408-8419. PubMed ID: 33899143
[TBL] [Abstract][Full Text] [Related]
8. Prospective Evaluation of Virtual MR Elastography With Diffusion-Weighted Imaging in Subjects With Nonalcoholic Fatty Liver Disease.
Hanniman E; Costa AF; Bowen CV; Abdolell M; Stueck A; McLeod M; Peltekian K; Rioux J; Clarke SE
J Magn Reson Imaging; 2022 Nov; 56(5):1448-1456. PubMed ID: 35285996
[TBL] [Abstract][Full Text] [Related]
9. MRE combined with FIB-4 (MEFIB) index in detection of candidates for pharmacological treatment of NASH-related fibrosis.
Jung J; Loomba RR; Imajo K; Madamba E; Gandhi S; Bettencourt R; Singh S; Hernandez C; Valasek MA; Behling C; Richards L; Fowler K; Sirlin CB; Nakajima A; Loomba R
Gut; 2021 Oct; 70(10):1946-1953. PubMed ID: 33214165
[TBL] [Abstract][Full Text] [Related]
10. Comparison of 2D Shear Wave Elastography, Transient Elastography, and MR Elastography for the Diagnosis of Fibrosis in Patients With Nonalcoholic Fatty Liver Disease.
Furlan A; Tublin ME; Yu L; Chopra KB; Lippello A; Behari J
AJR Am J Roentgenol; 2020 Jan; 214(1):W20-W26. PubMed ID: 31714842
[No Abstract] [Full Text] [Related]
11. Increased severity of liver fat content and liver fibrosis in non-alcoholic fatty liver disease correlate with epicardial fat volume in type 2 diabetes: A prospective study.
Brouha SS; Nguyen P; Bettencourt R; Sirlin CB; Loomba R
Eur Radiol; 2018 Apr; 28(4):1345-1355. PubMed ID: 29058029
[TBL] [Abstract][Full Text] [Related]
12. Magnetic Resonance vs Transient Elastography Analysis of Patients With Nonalcoholic Fatty Liver Disease: A Systematic Review and Pooled Analysis of Individual Participants.
Hsu C; Caussy C; Imajo K; Chen J; Singh S; Kaulback K; Le MD; Hooker J; Tu X; Bettencourt R; Yin M; Sirlin CB; Ehman RL; Nakajima A; Loomba R
Clin Gastroenterol Hepatol; 2019 Mar; 17(4):630-637.e8. PubMed ID: 29908362
[TBL] [Abstract][Full Text] [Related]
13. Liver Stiffness on Magnetic Resonance Elastography and the MEFIB Index and Liver-Related Outcomes in Nonalcoholic Fatty Liver Disease: A Systematic Review and Meta-Analysis of Individual Participants.
Ajmera V; Kim BK; Yang K; Majzoub AM; Nayfeh T; Tamaki N; Izumi N; Nakajima A; Idilman R; Gumussoy M; Oz DK; Erden A; Quach NE; Tu X; Zhang X; Noureddin M; Allen AM; Loomba R
Gastroenterology; 2022 Oct; 163(4):1079-1089.e5. PubMed ID: 35788349
[TBL] [Abstract][Full Text] [Related]
14. Clinical Characteristics of a Non-Alcoholic Fatty Liver Disease Population Across the Fibrosis Spectrum Measured by Magnetic Resonance Elastography: Analysis of Screening Data.
Andersen G; Plum-Mörschel L; Hockings PD; Morsing A; Palle MS; Svolgaard O; Flint A
Adv Ther; 2020 Dec; 37(12):4866-4876. PubMed ID: 33006125
[TBL] [Abstract][Full Text] [Related]
15. Diagnostic accuracy of elastography and magnetic resonance imaging in patients with NAFLD: A systematic review and meta-analysis.
Selvaraj EA; Mózes FE; Jayaswal ANA; Zafarmand MH; Vali Y; Lee JA; Levick CK; Young LAJ; Palaniyappan N; Liu CH; Aithal GP; Romero-Gómez M; Brosnan MJ; Tuthill TA; Anstee QM; Neubauer S; Harrison SA; Bossuyt PM; Pavlides M;
J Hepatol; 2021 Oct; 75(4):770-785. PubMed ID: 33991635
[TBL] [Abstract][Full Text] [Related]
16. Magnetic resonance elastography measured shear stiffness as a biomarker of fibrosis in pediatric nonalcoholic fatty liver disease.
Schwimmer JB; Behling C; Angeles JE; Paiz M; Durelle J; Africa J; Newton KP; Brunt EM; Lavine JE; Abrams SH; Masand P; Krishnamurthy R; Wong K; Ehman RL; Yin M; Glaser KJ; Dzyubak B; Wolfson T; Gamst AC; Hooker J; Haufe W; Schlein A; Hamilton G; Middleton MS; Sirlin CB
Hepatology; 2017 Nov; 66(5):1474-1485. PubMed ID: 28493388
[TBL] [Abstract][Full Text] [Related]
17. Association Between Obesity and Discordance in Fibrosis Stage Determination by Magnetic Resonance vs Transient Elastography in Patients With Nonalcoholic Liver Disease.
Caussy C; Chen J; Alquiraish MH; Cepin S; Nguyen P; Hernandez C; Yin M; Bettencourt R; Cachay ER; Jayakumar S; Fortney L; Hooker J; Sy E; Valasek MA; Rizo E; Richards L; Brenner DA; Sirlin CB; Ehman RL; Loomba R
Clin Gastroenterol Hepatol; 2018 Dec; 16(12):1974-1982.e7. PubMed ID: 29104128
[TBL] [Abstract][Full Text] [Related]
18. Comparative diagnostic accuracy of magnetic resonance elastography vs. eight clinical prediction rules for non-invasive diagnosis of advanced fibrosis in biopsy-proven non-alcoholic fatty liver disease: a prospective study.
Cui J; Ang B; Haufe W; Hernandez C; Verna EC; Sirlin CB; Loomba R
Aliment Pharmacol Ther; 2015 Jun; 41(12):1271-80. PubMed ID: 25873207
[TBL] [Abstract][Full Text] [Related]
19. Non-invasive screening of diabetics in primary care for NAFLD and advanced fibrosis by MRI and MRE.
Doycheva I; Cui J; Nguyen P; Costa EA; Hooker J; Hofflich H; Bettencourt R; Brouha S; Sirlin CB; Loomba R
Aliment Pharmacol Ther; 2016 Jan; 43(1):83-95. PubMed ID: 26369383
[TBL] [Abstract][Full Text] [Related]
20. Liver stiffness accuracy by magnetic resonance elastography in histologically proven non-alcoholic fatty liver disease patients: a Spanish cohort.
Lara Romero C; Liang JX; Fernández Lizaranzazu I; Ampuero Herrojo J; Castell J; Del Prado Alba C; Domínguez Pascual I; Romero Gómez M
Rev Esp Enferm Dig; 2023 Apr; 115(4):162-167. PubMed ID: 35791792
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
